UFH

Browse trials
V2  
List  

treatment    comparator  All cause death Bleeding Major bleeding Major bleeding Fatal bleeding Recurrent thromboembolic event  Symptomatic pulmonary embolism Deep vein thrombosis  non-fatal pulmonary embolism  asymptomatic DVT  wound haematoma / infection  fatal pulmonary embolism  Symptomatic venous thromboembolism (DVT, PE) transfusion      
Enoxaparinthrombosis prevention, in urologic surgery vs placebo--NSNS--NS--NS--NSNS
Heparinvenous thrombosis, in all type of patients vs intravenous heparin--NSNS-NS--------
UFHthrombosis prevention, in general surgery vs no treatment- by 56% --NS-- by 59% by 41% --NS--
UFHthrombosis prevention, in general surgery vs placebo-NS--NS-- by 58% NS--NS--
UFHthrombosis prevention, in general surgery vs aspirin-NS--NS--NSNS--NS--
UFHthrombosis prevention, in general surgery vs DHE-NS--NS--NSNS--NS--
UFHthrombosis prevention, in general surgery vs oral anticoagulant-NS----- by 72% NS-----
UFHthrombosis prevention, in all type of surgery vs no treatment- by 57% --NS-- by 57% NS--NS--
UFHthrombosis prevention, in all type of surgery vs placebo-NS--NS-- by 56% NS--NS--
UFHthrombosis prevention, in all type of surgery vs aspirin-NS--NS--NSNS--NS--
UFHthrombosis prevention, in all type of surgery vs DHE-NS--NS--NSNS--NS--
UFHthrombosis prevention, in all type of surgery vs oral anticoagulant-NS----- by 72% NS-----
UFHthrombosis prevention, in urologic surgery vs no treatment-NS--NS--NSNS--NS--
UFHthrombosis prevention, in urologic surgery vs placebo-NS--NS-- by 76% NS--NS--

 


- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons